ArticleDiscover oncology2025
A prognostic nomogram to predict clinical outcomes of patients with primary malignant and benign retroperitoneal tumors.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPrimary retroperitoneal tumor (PRT) is a relatively rare tumor with diverse histological and molecular types. We aim to develop and validate a concise prognostic nomogram for patients with benign and malignant PRT.
methodsThe clinical data of 206 PRT patients who underwent surgical management in authors' institution during January 2016 and December 2021 were analyzed. Logistic regression was used to select independent risk variables of binary outcome, while COX regression was performed for time-to-event. A predictive nomogram was developed based on multivariate analyses.
resultsOf the reported 206 PRTs, 113 patients were benign (54.85%) and 93 (45.15%) were malignant. Radical resection, extended radical resection and cytoreductive resection were performed in 141, 50 and 15 patients, respectively. The comprehensive complication index (CCI) was higher than 26.2% in 14 cases. Postoperative recurrence was experienced in 20 (9.7%) cases during the median 49 months. Nomogram was developed to predict severe complication and parameters included time of surgery, loss of blood and type of surgery with a moderate prediction capability [Area under curve (AUC) = 0.64)] after interval validation. While model for postoperative recurrence prediction includes parameters as chemotherapy, metastasis, combined resection and time of surgery with acceptable performance (AUC = 0.913). Overall survival is related to tumor size, metastasis and pathology as risk factors and the prediction capability was good (AUC = 0.800).
conclusionThe proposed nomogram showed favorable predictive accuracy for prognosis in patients with PRTs. This has the potential to contribute to clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.